Dashboard
Manage Tickers

ROIV Roivant Sciences Ltd.

Nasdaq roivant.com


$ 20.29 $ -0.27 (-1.31 %)    

Friday, 14-Nov-2025 15:55:00 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 20.29
$ 20.00
$ 20.36 x 163
$ 20.31 x 1,200
$ 20.03 - $ 21.16
$ 8.73 - $ 21.35
8,295,503
na
14.11B
$ 0.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-29-2025 03-31-2025 10-K
4 02-10-2025 12-31-2024 10-Q
5 11-12-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-30-2024 03-31-2024 10-K
8 02-13-2024 12-31-2023 10-Q
9 11-13-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 06-28-2023 03-31-2023 10-K
12 02-13-2023 12-31-2022 10-Q
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 06-28-2022 03-31-2022 10-K
16 02-14-2022 12-31-2021 10-Q
17 11-15-2021 09-30-2021 10-Q
18 09-21-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

citigroup-maintains-buy-on-roivant-sciences-raises-price-target-to-26
Citigroup Maintains Buy on Roivant Science...
11/11/2025 19:59:42

Citigroup analyst Samantha Semenkow maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $25...

looking-into-roivant-sciences-ltds-recent-short-interest
Looking Into Roivant Sciences Ltd's Recent...
11/11/2025 17:00:35

roivant-sciences-q2-adj-eps-028-beats-033-estimate-sales-1571m-miss-6947m-estimate
Roivant Sciences Q2 Adj. EPS $(0.28) Beats...
11/10/2025 12:02:53

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0....

earnings-scheduled-for-november-10-2025
Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

earnings-preview-for-roivant-sciences
Earnings Preview For Roivant Sciences
11/07/2025 14:01:16

citigroup-maintains-buy-on-roivant-sciences-raises-price-target-to-25
Citigroup Maintains Buy on Roivant Science...
10/29/2025 20:06:03

Citigroup analyst Samantha Semenkow maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $16...

roivant-sciences-files-for-mixed-shelf-offering-size-not-disclosed
Roivant Sciences Files For Mixed Shelf Off...
10/03/2025 20:44:41

-SEC Filing

goldman-sachs-maintains-buy-on-roivant-sciences-raises-price-target-to-24
Goldman Sachs Maintains Buy on Roivant Sci...
09/18/2025 16:47:02

Goldman Sachs analyst Corinne Jenkins maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $...

jefferies-maintains-buy-on-roivant-sciences-raises-price-target-to-20
Jefferies Maintains Buy on Roivant Science...
09/18/2025 14:58:25

Jefferies analyst Dennis Ding maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $18 to $20.

6-analysts-assess-roivant-sciences-what-you-need-to-know
6 Analysts Assess Roivant Sciences: What Y...
09/18/2025 14:00:55

jp-morgan-maintains-overweight-on-roivant-sciences-raises-price-target-to-20
JP Morgan Maintains Overweight on Roivant ...
09/18/2025 13:28:36

JP Morgan analyst Brian Cheng maintains Roivant Sciences (NASDAQ:ROIV) with a Overweight and raises the price target from $1...

guggenheim-maintains-buy-on-roivant-sciences-raises-price-target-to-21
Guggenheim Maintains Buy on Roivant Scienc...
09/18/2025 13:15:48

Guggenheim analyst Yatin Suneja maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $15 to ...

leerink-partners-maintains-outperform-on-roivant-sciences-raises-price-target-to-22
Leerink Partners Maintains Outperform on R...
09/18/2025 12:56:49

Leerink Partners analyst David Risinger maintains Roivant Sciences (NASDAQ:ROIV) with a Outperform and raises the price targ...

b-of-a-securities-maintains-neutral-on-roivant-sciences-raises-price-target-to-165
B of A Securities Maintains Neutral on Roi...
09/18/2025 12:53:41

B of A Securities analyst Chi Fong maintains Roivant Sciences (NASDAQ:ROIV) with a Neutral and raises the price target from ...

roivantpriovants-experimental-drug-shows-promise-in-rare-skin-disease-trial
Roivant/Priovant's Experimental Drug Shows...
09/17/2025 16:13:24

Brepocitinib showed significant improvements in skin and muscle symptoms in dermatomyositis, with reduced steroid use and consi...

lyft-oruka-therapeutics-roivant-sciences-workday-and-other-big-stocks-moving-higher-on-wednesday
Lyft, Oruka Therapeutics, Roivant Sciences...
09/17/2025 14:12:52

roivant-and-priovant-report-phase-3-results-for-brepocitinib-in-treating-debilitating-skin-muscle-disease
Roivant And Priovant Report Phase 3 Result...
09/17/2025 11:06:11

Roivant (NASDAQ:ROIV) and Priovant Therapeutics today announced positive results from the Phase 3 VALOR study evaluating brepoc...

pulmovant-wins-orphan-drug-status-in-japan-for-experimental-lung-disease-treatment
Pulmovant Wins Orphan Drug Status In Japan...
09/04/2025 11:23:26

Pulmovant, a clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases, and ...

citigroup-initiates-coverage-on-roivant-sciences-with-buy-rating-announces-price-target-of-16
Citigroup Initiates Coverage On Roivant Sc...
09/02/2025 12:02:05

Citigroup analyst Samantha Semenkow initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rating and announces Pri...

watching-roivant-sciences-shares-move-higher-traders-circulate-popular-newsletter-mentions-stock-as-a-buy
Watching Roivant Sciences; Shares Move Hig...
08/26/2025 19:03:21

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION